We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.04%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$836B
AUM Growth
+$19.8B
Cap. Flow
-$11.8B
Cap. Flow %
-1.42%
Top 10 Hldgs %
35.57%
Holding
3,089
New
135
Increased
1,850
Reduced
836
Closed
113

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.01B
2
AVGO icon
Broadcom
AVGO
+$1.49B
3
GEV icon
GE Vernova
GEV
+$1.19B
4
IP icon
International Paper
IP
+$1.05B
5
SCHW
Charles Schwab
SCHW
+$952M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.31B
2
CEG icon
Constellation Energy
CEG
+$1.94B
3
QCOM icon
Qualcomm
QCOM
+$1.74B
4
NVDA icon
NVIDIA
NVDA
+$1.71B
5
CRM icon
Salesforce
CRM
+$1.5B

Sector Composition

Rank Sector Weight
1 Technology 33.98%
2 Healthcare 14.89%
3 Financials 10.35%
4 Consumer Discretionary 10.11%
5 Communication Services 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OVID icon
2901
Ovid Therapeutics
OVID
$506M
$14K ﹤0.01%
17,396
WGSWW
2902
DELISTED
GeneDx Holdings Warrant
WGSWW
$6K ﹤0.01%
250,930
GCTS.WS
2903
GCT Semiconductor Holding Warrants
GCTS.WS
$20.3M
$6K ﹤0.01%
37,675
VSTEW
2904
DELISTED
Vast Renewables Limited Warrants
VSTEW
$5K ﹤0.01%
38,375
CSSE
2905
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$4K ﹤0.01%
20,300
-18,800
-48% -$4.82K
BFAC.WS
2906
DELISTED
Battery Future Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
BFAC.WS
$2K ﹤0.01%
55,855
RCFA.WS
2907
DELISTED
RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RCFA.WS
$2K ﹤0.01%
37,850
ONYXW
2908
DELISTED
Onyx Acquisition Co. I Warrant
ONYXW
$1K ﹤0.01%
37,750
SOAR.WS
2909
DELISTED
Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SOAR.WS
$1K ﹤0.01%
55,375
AAOI icon
2910
Applied Optoelectronics
AAOI
$11.7B
$0 ﹤0.01%
+11,828
New +$130K
ABSI icon
2911
Absci
ABSI
$1.61B
$0 ﹤0.01%
+25,586
New +$119K
ACET icon
2912
Adicet Bio
ACET
$78.1M
-959
Closed -$37K
ACHV icon
2913
Achieve Life Sciences
ACHV
$730M
$0 ﹤0.01%
+11,085
New +$53.4K
ACWI icon
2914
iShares MSCI ACWI ETF
ACWI
$33.5B
-14,893
Closed -$1.64M
ADCT icon
2915
ADC Therapeutics
ADCT
$132M
$0 ﹤0.01%
+22,476
New +$89.3K
APLT
2916
DELISTED
Applied Therapeutics
APLT
$0 ﹤0.01%
+30,675
New +$145K
AQST icon
2917
Aquestive Therapeutics
AQST
$547M
$0 ﹤0.01%
+23,848
New +$79.7K
ASIX icon
2918
AdvanSix
ASIX
$440M
-7,507
Closed -$215K
ASPI icon
2919
ASP Isotopes
ASPI
$541M
$0 ﹤0.01%
+12,812
New +$49.4K
ASRT
2920
DELISTED
Assertio
ASRT
-1,469
Closed -$22K
ATOS icon
2921
Atossa Therapeutics
ATOS
$24.2M
$0 ﹤0.01%
+2,718
New +$60.1K
ATRA icon
2922
Atara Biotherapeutics
ATRA
$77M
-198,326
Closed -$3.44M
AVDL
2923
DELISTED
Avadel Pharmaceuticals
AVDL
$0 ﹤0.01%
+29,391
New +$479K
BCAB icon
2924
BioAtla
BCAB
$5.56M
-256
Closed -$45K
BIRD icon
2925
Smartbird Inc
BIRD
$29.4M
-1,299
Closed -$19K

Similar funds

T. Rowe Price Associates's Q2 2024 Portfolio in Review

As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
  • T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
  • T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
  • T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
  • T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
  • T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
  • T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.

Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.